Mediwound Stock Filter Stocks by Fundamentals
| MDWD Stock | USD 21.00 0.51 2.49% |
Fundamental analysis of Mediwound allows traders to better anticipate movements in Mediwound's stock price by examining its financial health and performance throughout various phases of its business cycle.
Mediwound | Shares Owned by Insiders | Build AI portfolio with Mediwound Stock |
Mediwound ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mediwound's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mediwound's managers, analysts, and investors.Environmental | Governance | Social |
Mediwound Institutional Holders
Institutional Holdings refers to the ownership stake in Mediwound that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Mediwound's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mediwound's value.| Shares | State Street Corp | 2025-03-31 | 72.1 K | Sargent Investment Group, Llc | 2025-03-31 | 68.7 K | Ubs Group Ag | 2025-03-31 | 67.8 K | Dafna Capital Management Llc | 2025-03-31 | 64.5 K | Vanguard Group Inc | 2025-03-31 | 61.5 K | Legato Capital Management Llc | 2025-03-31 | 43.2 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 36.6 K | Meitav Dash Investments Ltd | 2025-03-31 | 31.5 K | Charles Schwab Investment Management Inc | 2025-03-31 | 22.5 K | Investors Finance Co Plc | 2025-03-31 | 872.1 K | Yelin Lapidot Holdings Management Ltd | 2025-03-31 | 858 K |
Mediwound Fundamentals
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (1.10) % | ||||
| Operating Margin | (1.32) % | ||||
| Current Valuation | 189.61 M | ||||
| Shares Outstanding | 10.81 M | ||||
| Shares Owned By Insiders | 17.96 % | ||||
| Shares Owned By Institutions | 43.87 % | ||||
| Number Of Shares Shorted | 889.18 K | ||||
| Price To Earning | 16.58 X | ||||
| Price To Book | 7.08 X | ||||
| Price To Sales | 11.53 X | ||||
| Revenue | 20.22 M | ||||
| Gross Profit | 2.77 M | ||||
| EBITDA | (27.93 M) | ||||
| Net Income | (30.22 M) | ||||
| Cash And Equivalents | 10.41 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 6.51 M | ||||
| Debt To Equity | 0.64 % | ||||
| Current Ratio | 1.61 X | ||||
| Book Value Per Share | 2.90 X | ||||
| Cash Flow From Operations | (13.62 M) | ||||
| Short Ratio | 14.84 X | ||||
| Earnings Per Share | (2.05) X | ||||
| Price To Earnings To Growth | (0.07) X | ||||
| Target Price | 30.67 | ||||
| Number Of Employees | 111 | ||||
| Beta | 0.32 | ||||
| Market Capitalization | 221.45 M | ||||
| Total Asset | 73.5 M | ||||
| Retained Earnings | (205.05 M) | ||||
| Working Capital | 25.62 M | ||||
| Current Asset | 50.4 M | ||||
| Current Liabilities | 5.21 M | ||||
| Net Asset | 73.5 M |
About Mediwound Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mediwound's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mediwound using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mediwound based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp |
Check out Mediwound Piotroski F Score and Mediwound Altman Z Score analysis. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.05) | Revenue Per Share | Quarterly Revenue Growth (0.20) | Return On Assets | Return On Equity |
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.